SMILES,name,logPerm*,TPSA,Table 4. Structures and data for DS5O=C([O-])c1ccccc1O,salycilate,-4.924,60.36,CC(=O)Oc1ccccc1C(=O)[O-],acetylsalicylate,-5.62,66.43,OCC(O)C(O)C(O)C(O)CO,mannitol,-6.745,121.37,CC( C )( C )NCC(O)c1cc(O)cc(O)c1,terbutaline,-6.42,72.71,C=CCc1cccc1OCC(O)CNC( C )C,alprenolol,-4.393,41.49,CC( C )NCC(O)COc1cccc2ccccc12,propanolol,-4.378,41.49,CC(=O)Nc1ccc(OCC(O)CNC( C )C)cc1,practolol,-6.046,70.58,CC( C )NCC(O)COc1ccc(CC(N)=O)cc1,atenolol,-6.7,84.58,COCCc1ccc(OCC(O)CNC( C )C)cc1,metoprolol,-4.569,50.72,CC12CCC(=O)C=C1CCC3C2CCC4( C )C(O)CCC34,testosterone,-4.286,37.3,O=C(O)c2cc(N=Nc1ccc(O)c(C(=O)O)c1)ccc2O,olsalazine,-6.959,139.78,CC(=O)CC(c1ccccc1)c3c(O)c2ccccc2oc3=O,warfarin,-4.417,67.51,CC14CCC(=O)C=C1CCC3C2CCC(C(=O)CO)C2( C )CC(O)C34,corticosterone,-4.263,74.6,CC14CCC(=O)C=C1CCC3C2CCC(O)(C(=O)CO)C2( C )CC(O)C34,hydrocortisone,-4.668,94.83,CCOC(=O)C1=C( C )NC( C )=C(C(=O)OC)C1c2cccc(C1)c2C1,felodipine,-4.644,64.64,CC4CC3C2CCC1=CC(=O)C=CC1( C )C2(F)C(O)CC3( C )C4(O)C(=O)CO,dexomethazone,-4.903,94.83,O=C(O)c3cc(N=Nc2ccc(S(=O)(=O)Nc1ccccn1)cc2)ccc3O,sulphasazaline,-6.886,141.32,,,,,*permeability[cm/s]through Caco-2 monolayers,,,,,,,,,,,,SMILES,name,logBB*,TPSA,Table 5. Structures and data for DS16CNC(=NC#N)NCCSCc1nc[nH]c1C,1,-1.42,88.89,Cc1csc(N=C(N)N)n1,2,-0.04,77.3,COc1cccnc1CCCCNc3nc(=O)c(Cc2ccc( C )nc2)c[nH]3,3,-2,92.8,CN( C )Cc4ccc(CSCCNc3nc(=O)c(Cc2ccc1ccccc1c2)c[nH]3)o4,4,-1.3,74.16,Cc3ccc(Cc2c[nH]c(NCCSCc1ccc(CN( C )C)o1)nc2=O)cn3,5,-1.06,87.05,Clc1cccc(Cl)c1NC2=NCCN2,6,0.11,36.42,COc2ccc(CN(CCN( C )C)c1ccccn1)cc2,7,0.49,28.6,CN( C )CCCN3c1ccccc1CCc2cccc23,8,0.83,6.48,CNC(=CN(=O)=O)NCCSCc1ccc(CN( C )C)o1,9,-1.23,86.26,CNC(=CC#N)NCCSCc1csc(N=C(N)N)n1,10,-0.82,125.15,CN( C )c2cc(c1n[nH]c(N)n1)ccn2,11,-1.17,83.73,CCNC(=NC#N)NCCSCc1ncccc1Br,12,-2.15,73.1,O=N(=O)c1cc[nH]c1NCCSCc2ncccc2Br,13,-0.67,86.53,O=N(=O)c1cc[nH]c1NCCSCc2ncccc2,14,-0.66,86.53,O=N(=O)c2c(Cc1ccccc1)c[nH]c2NCCSCc3ccccn3,15,-0.12,86.53,NC(N)=Nc2nc(c1ccccc1)cs2,16,-0.18,77.3,NC(N)=Nc2nc(c1cccc(N)c1)cs2,17,-1.15,103.32,CC(=O)Nc2cccc(c1csc(N=C(N)N)n1)c2,18,-1.57,106.4,CNC(=NC#N)Nc2cccc(c1csc(N=C(N)N)n1)c2,19,-1.54,137.51,CN( C )Cc2ccc(CSCCNc1[nH]ccc1N(=O)=O)o2,20,-1.12,90.02,CN( C )Cc3ccc(CSCCNc2[nH]cc(Cc1ccccc1)c2N(=O)=O)o3,21,-0.73,90.02,CN( C )Cc3ccc(c2cccc(Nc1[nH]ccc1N(=O)=O)c2)o3,22,-0.27,90.02,CN( C )Cc3ccnc(c2cccc(Nc1[nH]ccc1N(=O)=O)c2)c3,23,-0.28,89.77,CC(=O)NCCCOc2cccc(CN1CCCCC1)c2,24,-0.46,41.57,O=C(NCCCOc2cccc(CN1CCCCC1)c2)c3ccccc3,25,-0.24,41.57,OCCCOc2cccc(CN1CCCCC1)c2,26,-0.02,32.7,c3ccc(NCCCOc2cccc(CN1CCCCC1)c2)nc3,27,0.69,37.39,c3cc(CN1CCCCC1)cc(OCCCNc2nccs2)c3,28,0.44,37.39,c4cc(CN1CCCCC1)cc(OCCCNc3nc2ccccc2s3)c4,29,0.14,37.39,c4cc(CN1CCCCC1)cc(OCCCNc3nc2ccccc2o3)c4,30,0.22,50.53,CCC( C )=O,butanone,-0.08,17.07,c1ccccc1,benzene,0.37,0,CCC( C )CC,3-methylpentane,1.01,0,CCCC( C )CC,3-methylhexane,0.9,0,CC( C )O,2-propanol,-0.15,20.23,CC( C )CO,2-methylpropanol,-0.17,20.23,CCCC( C )C,2-methylpentane,0.97,0,CCC( C )( C )C,"2,2-dimethylbutane",1.04,0,FC(F)(F)CCl,"1,1,1-trifluoro-2-chloroethane",0.08,0,CC(Cl)(Cl)Cl,"1,1,1-trichloroethane",0.4,0,CCOCC,diethyl_ether,0,9.23,FC(F)OC(F)(F)C(F)Cl,enflurane,0.24,9.23,CCO,ethanol,-0.16,20.23,C=COCC(F)(F)F,fluroxene,0.13,9.23,FC(F)(F)C(Cl)Br,halothane,0.35,0,CCCCCCC,heptane,0.81,0,CCCCCC,hexane,0.8,0,FC(F)OC(Cl)C(F)(F)F,isoflurane,0.42,9.23,C,methane,0.04,0,CC1CCCC!,methylcyclopentane,0.93,0,N#N,nitrogen,0.03,47.58,CCCCC,pentane,0.76,0,CCCO,propanol,-0.16,20.23,CC( C )=O,propanone,-0.15,17.07,FC(Br)C(F)(F)F,teflurane,0.27,0,Cc1ccccc1,toluene,0.37,0,ClC=C(Cl)Cl,trichloroethene,0.34,0,,,,,*log(Cbrain/Cblood),,,,,,,,,,,,SMILES,name,logPc*,TPSA,Table 6. Structures and data for DS13 O=C(NCCNCC(O)COc2ccc(CCOCCOCC1CC1)cc2)N3CCC(O)CC3,H216/44,-0.983,112.52,CC( C )NCC(O)COc1ccc(CC(N)=O)cc1,atenolol,0.009,84.58,CC( C )NCC(O)COc1ccc(NC=O)cc1,H95/71,0.574,70.59,CC(=O)Nc1ccc(OCC(O)CNC( C )C)cc1,practolol,0.539,70.59,CCC(=O)Nc1ccc(OCC(O)CNC( C )C)cc1,H244/45,0.78,70.59,CC( C )NCC(O)COc1cccc2[nH]ccc12,pindolol,1.738,57.28,COCCc1ccc(OCC(O)CNC( C )C)cc1,metoprolol,1.963,50.72,C=CCOc1ccccc1OCC(O)CNC( C )C,oxprenolol,2.078,50.72,C=CCc1ccccc1OCC(O)CNC( C )C,alprenolol,2.384,41.49,,,,,*permeability[10^-6cm/s]through Caco-2 monolayers,,,,,,,,,,,,SMILES,name,logBB*,TPSA,Table 7. Structures and data for DS17CNCCCN3c1ccccc1CCc2ccccc23,1,1,15.26,CN( C )CCCN3c1ccccc1CCc2ccccc23,2,1.05,6.48,CN4CCN3c1ccccc1Cc2ccccc2C3C4,3,0.99,6.48,CN( C )CCC=C2c1ccccc1CCc3ccccc23,4,0.98,3.24,Cc1cccc3c1Oc2ccccc2C4(O)CCN( C )CC34,5,0.82,32.7,CN4CC3c1ccccc1Oc2ccc(Cl)cc22C3C4,6,1.03,12.47,FC(F)(F)c2ccc(N1CCNCC1)nc2Cl,7,1.64,28.16,O=C1CCCN1CCCCN3CCN(c2cc(C(F)(F)F)ccn2)CC3,8,0.16,39.68,Cc1cccc3c1Oc2ccccc2C4(O)CCNCC34,9,0.52,41.49,Clc4ccc3Oc1ccccc1C2CNCC2c3c4,10,0.39,21.26,CN4CCN3c1ncccc1Oc2ccccc2C3C4,11,0.53,28.6,C#CC4(O)CCC3C2C( C )CC1=C(CCC(=O)C1)C2CCC34C,12,0.4,37.3,Clc1cccc(Cl)c1N=C2NCCN2,13,0.11,36.42,NC(=O)N3c1ccccc1CCc2ccccc23,14,0,46.33,NC(=O)N4c1ccccc1C2OC2c3ccccc34,15,-0.33,58.86,CNC(=NC#N)NCCSCc1nc[nH]c1C,16,-1.42,88.89,CNC(=NN(=O)=O)NCCSCc1ccc(CN( C )C)o1,17,-1.23,98.62,COc2ccc(CN(CCN( C )C)c1ccccn1)cc2,18,0.49,28.6,COc1ccccc1CCCCnc3nc(=O)c(Cc2ccc( C )nc2)c[nH]3,19,-2,79.91,Cc3ccc(Cc2c[nH]c(NCCSCc1ccc(CN( C )C)o1)nc2=O)cn3,20,-1.06,87.05,O=c2[nH]c1ccccc1n2CCCN5CCC(n4c(=O)[nH]c3cc(Cl)ccc34)CC5,21,-0.78,78.83,C=CCC(N)c1ccccc1c2noc3ccccc23,22,0,52.05,Cc2nc1CCCCn1c(=O)c2CCN5CCC(c3noc4cc(F)ccc34)CC5,23,-0.02,64.17,Cc2nc1C(O)CCCn1c(=O)c2CCN5CCC(c3noc4cc(F)ccc34)CC5,24,-0.67,84.39,CC( C )c4nc(c2ncn3c1cccc(Cl)c1C(=O)N( C )Cc23)no4,25,-0.3,77.06,CN4Cc2c(c1noc(C( C )( C )O)n1)ncn2c3cccc(Cl)c3C4=O,26,-1.34,97.29,CN4Cc2c(c1noc(C( C )(O)CO)n1)ncn2c3cccc(Cl)c3C4=O,27,-1.82,117.51,Cc3ccc((Cc2c[nH]c(NCCCCc1ncc(Br)cc1C)nc2=O)cn3,28,-1.88,83.56,CN( C )Cc4ccc(CSCCNc3nc(=O)c(Cc2ccc1ccccc1c2)c[nH]3)o4,29,-1.3,74.16,CN( C )c2cc(c1n[nH]c(N)n1)ccn2,30,-1.17,83.73,O=N(=O)c1cc[nH]c1NCCSCc2ncccc2Br,31,-0.67,86.53,O=N(=O)c1cc[nH]c1NCCSCc2ccccn2,32,-0.66,86.53,NC(N)=Nc2nc(c1cccc(N)c1)cs2,33,-1.15,103.32,CC(=O)Nc2cccc(c1csc(N=C(N)N)n1)c2,34,-1.57,106.4,CN( C )Cc2ccc(CSCCNc1[nH]ccc1N(=O)=O)o2,35,-1.12,90.02,CN( C )Cc3ccc(CSCCNc2[nH]cc(Cc1ccccc1)c2N(=O)=O)o3,36,-0.73,90.02,CN( C )Cc3ccc(c2cccc(Nc1[nH]ccc1N(=O)=O)c2)o3,37,-0.27,90.02,CN( C )Cc3ccnc(c2cccc(Nc1[nH]ccc1N(=O)=O)c2)c3,38,-0.28,89.77,CC(=O)NCCCOc2cccc(CN1CCCCC1)c2,39,-0.46,41.57,O=C(NCCCOc2cccc(CN1CCCCC1)c2)c3ccccc3,40,-0.24,41.57,OCCCOc2cccc(CN1CCCCC1)c2,41,-0.02,32.7,c3ccc(NCCCOc2cccc(CN1CCCCC1)c2)nc3,42,0.69,37.39,c3cc(CN1CCCCC1)cc(OCCCNc2nccs2)c3,43,0.44,37.39,c4cc(CN1CCCCC1)cc(OCCCNc3nc2ccccc2s3)c4,44,0.14,37.39,c4cc(CN1CCCCC1)cc(OCCCNc3nc2ccccc2o3)c4,45,0.22,50.53,,,,,*log(Cbrain/Cblood),,,,,,,,,,,,SMILES,name,logPeff*,TPSA**,Cc2cc(=O)n(c1ccccc1)n2C,antipirine,-3.35,26.94,NC(=O)n3c1ccccc1ccc2ccccc23,carbamazepine,-3.37,48.03,CNCCCN3c1ccccc1CCc2ccccc23,desipramine,-3.36,15.26,CC(NC(CCc1ccccc1)C(=O)O)C(=O)C(=O)N2CCCC2C(=O)O,enalaprilat,-4.7,106.93,CC( C )n3c(C=CC(O)CC(O)CC(=O)O)c(c1ccc(F)cc1)c2ccccc23,fluvastatin,-3.62,82.69,NS(=O)(=O)c2cc(C(=O)O)c(NCc1ccco1)cc2Cl,furosemide,-5.3,131.01,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,hydrochlorothiazide,-5.4,135.11,CC(C(=O)O)c2CCCC(C(=O)c1ccccc1)c2,ketoprofen,-3.08,54.37,COCCc1ccc(OCC(O)CNC( C )C)cc1,metoprolol,-3.89,50.72,COc2ccc1cc(C( C )C(=O)O)ccc1c2,naproxen,-3.08,46.53,CC( C )NCC(O)COc1cccc2ccccc12,propanolol,-3.54,41.49,CC( C )( C )NCC(O)c1cc(O)cc(O)c1,terbutaline,-4.52,72.71,COc2ccc(CCN( C )CCCC(C#N)(c1ccc(OC)c(OC)c1)C( C )cc2OC,verapamil,-3.17,63.97,,,,,*effective permiability[10^-4cm/s]of human jejunum,,,,**sulfur fragments were also included in the calculations of PSA,,,,,,,,SMILES,name,FA%*,TPSA,Table 9. Structures and data for DS9COCCc1ccc(OCC(O)CNC( C )C)cc1,metoprolol,102,50.72,O=C3CN=C(c1ccccc1)c2cc(Cl)ccc2N3,nordiazepam,99,41.46,CN3C(=O)CN=C(c1ccccc1)c2cc(Cl)ccc23,diazepam,97,32.67,C=CCOc1ccccc1OCC(O)CNC( C )C,oxprenolol,97,50.72,Cc2cc(=O)n(c1ccccc1)n2C,phenazone,97,26.94,O=C3Nc1ccc(Cl)cc1C(c2ccccc2)=NC3O,oxazepam,97,61.69,C=CCc1ccccc1OCC(O)CNC( C )C,alprenolol,96,41.49,CC(=O)Nc1ccc(OCC(O)CNC( C )C)cc1,practolol,95,70.59,CC( C )NCC(O)COc1cccc2[nH]ccc12,pindolol,92,57.28,O=C(O)c4cn(C1CC1)c3cc(N2CCNCC2)c(F)cc3c4=O,ciprofloxacin,69,74.57,Cc1ccccc1N3C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC3C,metolazone,64,92.5,NCC1CCC(C(=O)O)CC1,tranexamic acid,55,63.32,CC( C )NCC(O)COc1ccc(CC(N)=O)cc1,atenolol,54,84.58,CCN1CCCC1CNC(=O)c2cc(S(N)(=O)=O)ccc2OC,sulpiride,36,101.73,OCC(O)C(O)C(O)C(O)CO,mannitol,26,121.37,O=C(O)P(=O)(O)O,foscarnet,17,94.83,O=C(O)c3cc(N=Nc2ccc(S(=O)(=O)Nc1ccccn1)cc2)ccc3O,sulfasalazine,12,141.32,O=C(O)c2cc(N=Nc1ccc(O)c(C(=O)O)c1)ccc2O,olsalazine,2.3,139.78,O=C(CO)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO,lactulose,0.6,197.36,OCC3OC(OCC2OC(OC1(CO)OC(CO)C(O)C1O)C(O)C(O)C2O)C(O)C(O)C3O,raffinose,0.3,268.68,